Synthesis 2014; 46(23): 3263-3267
DOI: 10.1055/s-0034-1378554
paper
© Georg Thieme Verlag Stuttgart · New York

Synthesis of 4-Halogenated 3-Fluoro-6-methoxyquinolines: Key Building Blocks for the Synthesis of Antibiotics

Thomas Flagstad
a   Department of Chemistry, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark   Fax: + 45(4593)3968   Email: ten@kemi.dtu.dk
,
Mette T. Petersen
a   Department of Chemistry, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark   Fax: + 45(4593)3968   Email: ten@kemi.dtu.dk
,
Daniel M. Hinnerfeldt
a   Department of Chemistry, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark   Fax: + 45(4593)3968   Email: ten@kemi.dtu.dk
,
Michael Givskov
b   Department of International Health, Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark
c   Singapore Centre on Environmental Life Sciences Engineering, Nanyang Technological University, Singapore 637551, Singapore
,
Thomas E. Nielsen*
a   Department of Chemistry, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark   Fax: + 45(4593)3968   Email: ten@kemi.dtu.dk
c   Singapore Centre on Environmental Life Sciences Engineering, Nanyang Technological University, Singapore 637551, Singapore
› Author Affiliations
Further Information

Publication History

Received: 11 June 2014

Accepted after revision: 07 July 2014

Publication Date:
28 August 2014 (online)


Abstract

A practical and scalable 4-step route is presented for the synthesis of 4-bromo-3-fluoro-6-methoxyoquinoline and 3-fluoro-4-iodo-6-methoxyoquinoline from readily available 2,4-dichloro-3-fluoroquinoline with an overall yield of 81–85%. Halogenated quinoline building blocks have found much use in antimicrobial drug discovery, and the method reported here would be useful for the synthesis of these compounds.

Supporting Information

 
  • References


    • For selected articles on fluoroquinolines, see:
    • 2a Horchler CL, McCauley JP, Hall JE, Snyder DH, Moore WC, Hudzik TJ, Chapdelaine MJ. Bioorg. Med. Chem. 2007; 15: 939
    • 2b Hoeglund IP. J, Silver S, Engstroem MT, Salo H, Tauber A, Kyyroenen H.-K, Saarenketo P, Hoffren A.-M, Kokko K, Pohjanoksa K, Sallinen J, Savola J.-M, Wurster S, Kallatsa OA. J. Med. Chem. 2006; 49: 6351
    • 2c Takahashi K, Kamiya M, Sengoku Y, Kohda K, Kawazoe Y. Chem. Pharm. Bull. 1988; 36: 4630
    • 2d Kato T, Hakura A, Mizutani T, Saeki K. Mutat. Res. 2000; 465: 173
  • 3 Stein GE. Clin. Infect. Dis. 1996; 23 (Suppl. 1): S19
  • 4 Black MT, Stachyra T, Platel D, Girard A.-M, Claudon M, Bruneau J.-M, Miossec C. Antimicrob. Agents Chemother. 2008; 52: 3339
  • 5 Surivet J.-P, Zumbrunn C, Rueedi G, Hubschwerlen C, Bur D, Bruyère T, Locher H, Ritz D, Keck W, Seiler P, Kohl C, Gauvin J.-C, Mirre A, Kaegi V, Dos Santos M, Gaertner M, Delers J, Enderlin-Paput M, Boehme M. J. Med. Chem. 2013; 56: 7396
  • 6 Novexel Discontinues Development of NXL 101 . Novexel Press Release; Paris: 2008. June 3
  • 7 For a recent review, see: Mayer C, Janin YL. Chem. Rev. 2014; 114: 2313
    • 8a Bigot A, Mignani S, Ronan B, Tabart M, Viviani F. US Patent Appl. US 20050032800 A1, 2005 ; Chem. Abstr. 2005, 142, 219160
    • 8b Miller WH, Pendrak I, Seefeld MA. Patent PCT Int. Appl. WO 2006002047 A2, 2006 ; Chem. Abstr. 2006, 144, 108362
    • 8c Miller WH, Rouse MB, Seefeld MA. Patent PCT Int. Appl. WO 2006014580 A1, 2006 ; Chem. Abstr. 2006, 144, 212789
    • 8d Miller WH, Rouse MB, Seefeld MA. Patent PCT Int. Appl. WO 2006081289 A2, 2006 ; Chem. Abstr. 2006, 145, 188914
    • 8e Daines RA, Price AT. Patent PCT Int. Appl. WO 2007016610 A2, 2007 ; Chem. Abstr. 2007, 146, 229364
    • 8f Baque F, Carry J.-C, El-Ahmad Y, Evers M, Hubert P, Malleron J.-L, Mignani S, Pantel G, Tabart M, Viviani F. Patent PCT Int. Appl. WO 2002040474 A2 2002, 2002 ; Chem. Abstr. 2002, 136, 386033
    • 8g Fukuda Y, Kaelin DE. Jr, Singh SB. Patent PCT Int. Appl. WO 2013003383 A1, 2013 ; Chem. Abstr. 2013, 158, 158577.
  • 9 Li B, Zhang Z, Mangano M. Org. Process Res. Dev. 2008; 12: 1273
  • 10 Inspired by the selective Sonogashira coupling in the 2-position of 2,4-dichloroquinolines: Reddy EA, Islam A, Mukkanti K, Bandameedi V, Bhowmik DR, Pal M. Beilstein J. Org. Chem. 2009; 5: 32
  • 11 The desired intermediate, 4-chloro-3-fluoro-6-methoxy-quinoline (7), has also been preparred by fluorination of 4-chloro-6-methoxyquinoline in 31% yield (0.4 g), see ref. 8c
  • 12 Farhanullah Kim SY, Yoon EJ, Choi EC, Kim S, Kang T, Samrin F, Puri S, Lee J. Bioorg. Med. Chem. 2006; 14: 7154
  • 14 Wolf C, Tumambac GE, Villalbos CN. Synlett 2003; 1801
  • 15 A reviewer noted that this transformation might require flame-dried NaI. However, in our hands the reaction proceeded in 95% yield using NaI from the shelf.